Table 6 Patient’s characteristics across the five risk intervals
PIM2 risk | < 1% | 1–5% | 5–15% | 15–30% | > 30% | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Family transport group (n = 344) | EMS transport group (n = 511) | p-values | Family transport group (n = 391) | EMS transport group (n = 1010) | p-values | Family transport group (n = 89) | EMS transport group (n = 312) | p-values | Family transport group (n = 24) | EMS transport group (n = 87) | p-values | Family transport group (n = 13) | EMS transport group (n = 146) | p-values | |
Chronic conditions (%) | 201 (58.4) | 191 (37.4) | < 0.01* | 244 (62.4) | 383 (37.9) | < 0.01* | 64 (71.9) | 149 (47.8) | < 0.01* | 20 (83.3) | 36 (41.4) | < 0.01* | 12 (92.3) | 63 (43.2) | < 0.01* |
Distance (km) (IQR) | 4.7 (2.9–8.4) | 9.5 (4.3–16) | < 0.01* | 5.7 (3.3-9.8) | 9.6 (4.8-15) | < 0.01* | 4.5 (2.7-8.5) | 12 (6.4-25.8) | <0.01* | 7.0 (3.7–21.7) | 15.5 (10.1–46.0) | < 0.01* | 9.5 (4.8–17.3) | 10.4 (4.9–17.3) | 0.507 |
Mortality (%) | 2 (0.6) | 1 (0.2) | 0.568 | 2 (0.5) | 4 (0.4) | 0.674 | 1 (1.1) | 4 (1.3) | 1 | 1 (4.2) | 5 (5.7) | 1 | 3 (23.1) | 65 (44.5) | 0.156 |